European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

European equities traded in the US as American depositary receipts kicked off the week trending lower late Monday morning, declining 0.37% to 1,326.63 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and pharmaceutical company Novo Nordisk (NVO), which rose 11% and 1.8% respectively. They were followed by internet browser company Opera (OPRA) and telecommunications company Ericsson (ERIC), which were up 1.7% and 0.5% respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit (GNFT) and furniture maker Natuzzi (NTZ), which lost 5.4% and 3.4% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and oil and gas company TotalEnergies (TTE), which dropped 3% and 2.6% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and cruise line operator Carnival (CUK), which were up 6.5% and 3.1% respectively. They were followed by biopharmaceutical companies Verona Pharma (VRNA) and Mereo BioPharma Group (MREO), which rose 0.6% each.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company TC Biopharm (TCBP), which dropped 4.5% and 4.2% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and oil and gas company BP (BP), which were off 2.6% and 2.1% respectively.